CSL Limited
CSL Limited (CSL.AX) Financial Performance & Income Statement Overview
Explore the financials of CSL Limited (CSL.AX), including yearly and quarterly data on income, cash flow, and balance sheets.
CSL Limited (CSL.AX) Income Statement & Financial Overview
Access detailed annual and quarterly income data for CSL Limited CSL.AX financial performance.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $8.21B | $6.76B | $8.36B | $5.92B |
| Cost of Revenue | $3.93B | $3.68B | $4.07B | $3.29B |
| Gross Profit | $4.28B | $3.08B | $4.29B | $2.63B |
| Gross Profit Ratio | $0.52 | $0.46 | $0.51 | $0.44 |
| R&D Expenses | $646.00M | $769.94M | $699.10M | $647.34M |
| SG&A Expenses | $1.18B | $1.17B | $1.33B | $1.17B |
| Operating Expenses | $2.30B | $1.94B | $1.60B | $1.82B |
| Total Costs & Expenses | $6.24B | $5.62B | $5.68B | $5.10B |
| Interest Income | $27.23M | $19.25M | $20.87M | $3.24M |
| Interest Expense | $213.00M | $337.31M | $389.29M | $234.26M |
| Depreciation & Amortization | $476.00M | $515.66M | $447.63M | $441.88M |
| EBITDA | $3.23B | $1.75B | $3.19B | $1.36B |
| EBITDA Ratio | $0.39 | $0.26 | $0.38 | $0.21 |
| Operating Income | $1.98B | $1.14B | $2.69B | $816.13M |
| Operating Income Ratio | $0.24 | $0.17 | $0.32 | $0.14 |
| Other Income/Expenses (Net) | $563.00M | -$304.34M | -$343.32M | -$128.29M |
| Income Before Tax | $2.54B | $1.49B | $3.49B | $687.84M |
| Income Before Tax Ratio | $0.31 | $0.22 | $0.42 | $0.12 |
| Income Tax Expense | $484.00M | $204.64M | $478.94M | $94.27M |
| Net Income | $2.007B | $1.11B | $2.91B | $593.56M |
| Net Income Ratio | $0.24 | $0.16 | $0.35 | $0.10 |
| EPS | $4.15 | $2.33 | $4.11 | $1.23 |
| Diluted EPS | $4.13 | $2.32 | $4.09 | $1.22 |
| Weighted Avg Shares Outstanding | $483.88M | $483.25M | $482.83M | $482.37M |
| Weighted Avg Shares Outstanding (Diluted) | $485.96M | $485.75M | $484.98M | $484.59M |
The company's financials show resilient growth, with revenue advancing from $5.92B in Q4 2023 to $8.21B in Q2 2025. Gross profit remained healthy with margins at 52% in Q2 2025 compared to 44% in Q4 2023. Operating income hit $1.98B last quarter, sustaining a consistent 24% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $3.23B. Net income rose to $2.007B, while earnings per share reached $4.15. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan